Assessing the prevalence and characteristics of self-reported penicillin allergy in Saudi Arabian population: A nationwide cross-sectional study
Saudi Pharmaceutical Journal · 2023-02 · 31 (2) · 222-227
DOI: 10.1016/j.jsps.2022.12.006 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Saudi Pharmaceutical Journal, 2023-02. Verfasst von Shuroug A Alowais und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Being allergic to penicillin can lead to the overuse of broad-spectrum antibiotics, contributing to the growing problem of multidrug resistance. Knowing the exact allergy history is essential as some circumstances may allow reinitiating penicillin. This study focused on assessing the prevalence and characteristics of self-reported penicillin allergy in the Saudi Arabian population.
Methods
We conducted a nationwide cross-sectional study via an electronic self-administered questionnaire directed toward the Saudi Arabian general adult population. Variables about respondent demographics as well as type and characteristics of the allergy were collected.
Results
One hundred ninety-three out of 2022 participants who completed the survey (9.5%) reported allergy to penicillin, with the most reported reaction being anaphylaxis in 89 participants (46.1%), non-anaphylaxis reported by 69 participants (35.8%). Twenty-two participants (11.4%) were identified as not having a true allergy due to reporting a tolerability issue or a non-penicillin-type agent. About 38% reported that the allergy occurred more than ten years ago.
Conclusion
This is the first study to report the prevalence and characteristics of self-reported penicillin allergy in Saudi Arabia. The data from this study provides valuable information to consider starting in-hospital penicillin de-labeling programs and providing evidence for healthcare providers to consider re-challenging certain qualified patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
- King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia.
- King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
- Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Zitieren
APA
Alowais, S. A., Almohareb, S. N., Bin Saleh, K., Asiri, I. M., Badreldin, H. A., Alqazlan, L., Albasseet, M., Fetyani, L., Alshehri, L. A., & Almutairi, A. M. (2023). Assessing the prevalence and characteristics of self-reported penicillin allergy in Saudi Arabian population: A nationwide cross-sectional study. Saudi Pharmaceutical Journal, 31(2), 222-227. https://doi.org/10.1016/j.jsps.2022.12.006
Vancouver
Alowais SA, Almohareb SN, Bin Saleh K, Asiri IM, Badreldin HA, Alqazlan L, et al. Assessing the prevalence and characteristics of self-reported penicillin allergy in Saudi Arabian population: A nationwide cross-sectional study. Saudi Pharmaceutical Journal. 2023;31(2):222-227. doi:10.1016/j.jsps.2022.12.006
BibTeX
@article{Alowais2023,
author = {Alowais, Shuroug A and Almohareb, Sumaya N and Bin Saleh, Khalid and Asiri, Ibrahim M and Badreldin, Hisham A and Alqazlan, Lena and Albasseet, Maram and Fetyani, Lolwa and Alshehri, Lina Ali and Almutairi, Areej M},
title = {Assessing the prevalence and characteristics of self-reported penicillin allergy in Saudi Arabian population: A nationwide cross-sectional study},
journal = {Saudi Pharmaceutical Journal},
year = {2023},
volume = {31},
number = {2},
pages = {222--227},
doi = {10.1016/j.jsps.2022.12.006}
}
EUVIMED